Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pueraria tuberosa extract is a botanical extract derived from the tubers of *Pueraria tuberosa* (commonly known as Indian Kudzu or Vidarikanda), a perennial herb used in traditional Ayurvedic medicine. The extract contains several bioactive isoflavonoids, including puerarin, daidzein, genistein, and biochanin-A. It is being researched for various therapeutic applications, including Friedreich's ataxia (FRDA), type 2 diabetes, menopausal osteoporosis, and inflammatory conditions. In preclinical models of FRDA, the extract has been shown to improve locomotion defects and increase aconitase activity. It also exhibits antioxidant, anti-inflammatory, and estrogenic properties, acting as a modulator of estrogen receptors and other metabolic pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pueraria tuberosa extract.